AIDS Weekly
Susan Hasty, Publisher
Table of Contents . . . January 14th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
AIDS and HIV Immunotherapy - Healthy Patients With Low CD4 Counts May Retain High Natural Killer Cell Function
AIDS and HIV Therapy - Early Antiretroviral Efficacy Predicts Long-Term Success
AIDS and HIV Therapy - Modified Reverse Transcriptase Inhibitors Effective Against Resistant Viral Strains
AIDS and HIV Tuberculosis Therapy - Isoniazid Requires Complements For Long-Term Protection
AIDS and HIV Vaccine - Interleukins Can Be Effective Adjuvants For Mucosal Administration
Coinfection - HIV Enhances Risk For Hepatitis C When Sexual Transmission Sole Risk Factor
HIV Therapies - Test Developed That Detects HIV As It Infects Normal Cells
AIDS Therapies - Atazanavir/Saquinavir Once-Daily Is Effective And Safe
AIDS Therapies - Injectable T-20 Provides Rapid And Potent Viral Suppression
AIDS Therapies - Lopinavir/Ritonavir Combination Avoids Resistance
AIDS Therapies - PRO 140 Produced Complete And Sustained Control Of Infection In Vivo
AIDS Therapies - Structured Treatment Interruptions Evaluated In HIV Patients
AIDS Therapies - Studies Highlight Promising Results In Drug Development
AIDS Therapies - Test Helps Doctors Find Better Treatment Options
AIDS and HIV Tuberculosis - Doubly Infected Patients In High-Risk Environments Have Higher TB Recurrence Risk
AIDS and HIV Vaccine - Nef-Deleted Vaccine Strain Replicates In CD4 Cells
Advocacy - South African Government Appeals Decision Forcing It To Supply Drug
Drug Resistance - New Data Show HIV Resistance Test May Be Useful In Early Failures
Ethics - General Accounting Office Probes Tainted Medical Research
Funding - 6000 Florida AIDS Patients Will Have Care Reduced
Funding - Yale AIDS Research Program Receives $10.7 Million NIMH Grant
HIV Vaccine - NIAID, Merck To Collaborate On HIV Vaccine Development
Multifocal Leukoencephalopathy - Researchers Report Success Against Brain Disease In HIV Patient
Risk Factors - Successful HAART Reduces Risk Of Pneumonia
Tuberculosis - HIV Doubles TB Caseload; Strong TB Treatment Program Could Curb Effect
Virology - AIDS Research Group to Share Drug Revenues With Samoan Village Healers
Virology - University of Pittsburgh and Pittsburgh VA Get $8 Million to Study Alcohol and HIV Interactions
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
